CMS last week signaled plans to revisit an underused tool for gathering clinical evidence on medical technologies with the opening of a public comment period on coverage with evidence development.
Under coverage with evidence, or CED, CMS provides reimbursement for services on the condition that additional data is collected via patient participation in a registry or clinical trial
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?